David Baxley Spetzler
President · 3 filings · Latest: Sep 3, 2026
Caris Life Sciences, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
CAI | David Baxley Spetzler | President | Sep 4, 2026 | Sale | $24.76 | 119,212 | $3.0M | 1,182,871 | |
CAI | David Baxley Spetzler | President | Sep 4, 2026 | Option Exercise | $2.44 | 250,000 | $610.0K | 1,302,083 | |
CAI | David Baxley Spetzler | President | Sep 3, 2026 | Sale | $24.86 | 478,000 | $11.9M | 1,052,083 | |
CAI | David Baxley Spetzler | President | Sep 3, 2026 | Option Exercise | $2.44 | 1,000,000 | $2.4M | 1,530,083 | |
CAI | DAVID SPETZLER | — | Sep 4, 2026 | Proposed Sale | $24.76 | 119,212 | $3.0M | — | |
CAI | DAVID SPETZLER | — | Sep 3, 2026 | Proposed Sale | $24.86 | 478,000 | $11.9M | — |